A carregar...
Imeglimin prevents human endothelial cell death by inhibiting mitochondrial permeability transition without inhibiting mitochondrial respiration
Imeglimin is the first in a new class of oral glucose-lowering agents, having recently completed its phase 2b trial. As Imeglimin did show a full prevention of β-cell apoptosis, and since angiopathy represents a major complication of diabetes, we studied Imeglimin protective effects on hyperglycemia...
Na minha lista:
| Publicado no: | Cell Death Discov |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Publishing Group
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4979505/ https://ncbi.nlm.nih.gov/pubmed/27551496 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddiscovery.2015.72 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|